Latest Quarterly Sales News

Freehill Mining Limited (ASX: FHS) halved its operating cash outflow to A$189,000 in the September quarter as record monthly sales in September helped offset weather disruption. The company is also moving towards November permitting for its Blanco y Negro copper-gold project, while seeking up to A$607,000 through an entitlement offer.

Syrah Resources delivered a stronger Balama quarter and began ramping Vidalia’s US anode-material facility towards commercial sales. But higher cost guidance, negative operating cash flow and unresolved loan defaults leave the balance sheet as the central risk.

Comvita has moved from NZ$62.4 million of net debt to NZ$0.5 million of net cash in a year, while FY27 first-quarter sales rose 4.6%. The sharper test now is whether its operating reset can convert a stronger balance sheet into durable shareholder returns, with no FY27 dividend expected and board control still contested.

PT ANTAM (Persero) Tbk (ASX:ATM, IDX:ANTM) delivered stronger nine-month 2026 operating volumes across gold, ferronickel, bauxite and alumina, while advancing Indonesia’s battery and mineral-processing agenda. The unaudited report also details Rp5.05 trillion in dividends, but provides no nine-month revenue or profit figures.

PLS has paired record quarterly production with a 20-year Fortescue power agreement expected to cut Pilgangoora’s FOB operating costs by A$15 to A$20 a tonne. The deal adds to a much larger investment cycle, with the A$1.9 billion P2000 expansion now under construction and FY27 capital guidance lifted to A$1.13 billion to A$1.195 billion.

Nova Eye Medical delivered 30% year-on-year sales growth in the September quarter, alongside positive operating cash flow and EBITDA. The company confirmed FY27 guidance, but is still seeking to replace a related-party funding facility carrying 15% interest.

Alara Resources delivered its strongest quarterly copper sales since commercial operations began, while production remained above nameplate capacity at its Oman mine. Yet the company says the parent may need to raise about A$6 million in FY27 to cover a projected cash shortfall.

ReNerve has reported its strongest quarter yet, with sales climbing to $584,000 as the medical device company expands across Asia-Pacific. The growth came alongside a secured funding drawdown, leaving the company with $1.62 million in cash but continued negative operating cash flow.

Newmont Corporation (ASX:NEM) delivered record third-quarter adjusted net income of US$2.3 billion and US$1.9 billion in free cash flow, despite lower gold output and higher unit costs. The gold major also moved Red Chris closer to a potential US$4.2 billion to US$4.8 billion development decision in early 2027.

Energy Action delivered sharp growth in first-quarter sales orders and its contracted cash pipeline, but the expansion came with higher costs and negative operating cash flow. The company had $0.93 million of stated liquidity at quarter-end, with a $724,999 secured loan due in December.

Karoon Energy more than doubled quarterly production to 2.27 million barrels of oil equivalent as revenue climbed 64% to US$191.6 million. But the SPS-92 electrical fault remains unresolved, while the company balances growth spending, shareholder returns and US$269.2 million of net debt.

Phoslock Environmental Technologies Limited (ASX:PET) reduced its September-quarter operating cash outflow to A$21,000 as sales receipts more than doubled from the previous quarter. The company has paused manufacturing in China after storage capacity was reached, while new lanthanum formulations and a first Phoslock 10 field trial move forward.